tirzepatide or semaglutide for pcos GLP-1 care is not one-size-fits-all—especially when #pmos is part of the picture. 💛 Semaglutide, tirzepatide, microdosing, and oral GLP-1 options can all support metabolic health in different ways, but the right choice Semaglutide: A Promising Treatment for

If progress stalls or side effects are bothersome, the plan is adjusted, a level of follow-up that a single walk-in visit rarely provides

Plus, they come with side effects including nausea, vomiting, diarrhea, and gastric discomfort

Protocol 1: standard weight loss titration (10 mg/mL vial) Goal: Gradual dose escalation following the standard tirzepatide titration schedule

Signs that you may be ready to increase your dose Your provider will typically consider a dose increase when: You have been on your current dose for at least 4 weeks with no significant side effects Nausea, vomiting, or stomach discomfort from the previous dose increase has resolved Your weight loss has plateaued at the current dose, and you have not yet reached your goal Your blood sugar levels (if you have diabetes) are not yet in your target range Signs you are not ready to increase Your provider will typically delay a dose increase if: You are still experiencing nausea, vomiting, diarrhea, or stomach pain from your current dose You have missed doses recently due to side effects You have experienced any serious adverse event at the current dose that has not fully resolved Do you need to reach 15 mg

Its fascinating to see how evolving manufacturing complexities and innovations in peptides, biologics, and advanced formulations are redefining competitive dynamics